HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rapid resolution following chemotherapy of Broca's dysphasia due to recurrent anaplastic astrocytoma.

Abstract
A middle-aged man re-presented with a Broca's aphasia due to a recurrent fronto-cingulate anaplastic astrocytoma. Although the language disturbance did not improve with dexamethasone therapy, within 4 weeks of treatment with procarbazine, CCNU and vincristine, the dysphasia had almost completely resolved. The anatomico-functional aspects and possible mechanisms of production and resolution of the aphasia are discussed. Assessment of dysphasias in patients undergoing intensive therapy for brain neoplasms is often neglected, but it can provide good objective information about the efficacy of therapy.
AuthorsS J Cole, D E Fraser, I R Whittle
JournalBritish journal of neurosurgery (Br J Neurosurg) Vol. 8 Issue 2 Pg. 205-8 ( 1994) ISSN: 0268-8697 [Print] England
PMID7917094 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Procarbazine
  • Vincristine
  • Lomustine
Topics
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Aphasia, Broca (drug therapy)
  • Astrocytoma (drug therapy)
  • Fatal Outcome
  • Follow-Up Studies
  • Frontal Lobe (drug effects)
  • Gyrus Cinguli (drug effects)
  • Humans
  • Lomustine (administration & dosage)
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (drug therapy)
  • Neurologic Examination (drug effects)
  • Neuropsychological Tests
  • Procarbazine (administration & dosage)
  • Tomography, X-Ray Computed
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: